Form 8-K - Current report:
SEC Accession No. 0001193125-20-208095
Filing Date
2020-08-03
Accepted
2020-08-03 16:29:43
Documents
6
Period of Report
2020-07-29
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d30256d8k.htm 8-K 22367
2 EX-1.1 d30256dex11.htm EX-1.1 203081
3 EX-5.1 d30256dex51.htm EX-5.1 4584
4 EX-99.1 d30256dex991.htm EX-99.1 7823
5 EX-99.2 d30256dex992.htm EX-99.2 5626
6 GRAPHIC g30256g37n05.jpg GRAPHIC 7220
  Complete submission text file 0001193125-20-208095.txt   254839
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 201069562
SIC: 2834 Pharmaceutical Preparations